114 related articles for article (PubMed ID: 33190719)
21. Cervical cancer 1: an overview of screening and diagnosis.
Jefferies H
Nurs Times; 2008 Nov 4-10; 104(44):26-7. PubMed ID: 19014130
[TBL] [Abstract][Full Text] [Related]
22. [How can we improve cervical cancer screening: What can we learn from mistakes?].
Grigore M; Nandrean A; Gafitanu D
Bull Cancer; 2020 Mar; 107(3):322-327. PubMed ID: 32061377
[TBL] [Abstract][Full Text] [Related]
23. [Organization of mass-screening for early detection of cervical cancer and its precancerous conditions. I. report: Demonstration of a computer assisted mass-screening program (Model Rostock) (author's transl)].
Neumann HG; Seidenschnur G; Büttner HH; Bader G
Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):893-9. PubMed ID: 765193
[TBL] [Abstract][Full Text] [Related]
24. ASC-US diagnosis and triage.
Del Mistro A
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S2-4. PubMed ID: 17727939
[No Abstract] [Full Text] [Related]
25. Diagnosing Premalignant Lesions of Uterine Cervix in A ResourceConstraint Setting: A Narrative Review.
Grema BA; Aliyu I; Michael GC; Mafala MB
West Afr J Med; 2019; 36(1):48-53. PubMed ID: 30924116
[TBL] [Abstract][Full Text] [Related]
26. Reducing overuse of cervical cancer screening: A systematic review.
Alber JM; Brewer NT; Melvin C; Yackle A; Smith JS; Ko LK; Crawford A; Glanz K
Prev Med; 2018 Nov; 116():51-59. PubMed ID: 30149037
[TBL] [Abstract][Full Text] [Related]
27. Early prevention and screening of cervical cancer in a developing country.
Carvallo-Michelena A; Rojas-Dominguez JL; Piscoya A
Am J Prev Med; 2015 Mar; 48(3):e1. PubMed ID: 25701946
[No Abstract] [Full Text] [Related]
28. [Rare cytologic findings by gynecologic examinations (author's transl)].
Büttner HH; Beust M
Arch Geschwulstforsch; 1977; 47(4):304-10. PubMed ID: 921484
[No Abstract] [Full Text] [Related]
29. Early prevention and screening of cervical cancer in a developing country-reply.
Ekwueme DU; Saraiya M
Am J Prev Med; 2015 Mar; 48(3):e2-3. PubMed ID: 25701947
[No Abstract] [Full Text] [Related]
30. [Screening and diagnosis of cervical cancer].
Boulanger JC; Naepels P
Rev Prat; 2001 Sep; 51(13):1426-31. PubMed ID: 11601071
[TBL] [Abstract][Full Text] [Related]
31. [Results of mass screening for uterine precancerous conditions in Czechoslovakia during 1953-1967].
Vácha K
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1969; 12(5):557-66. PubMed ID: 5267646
[No Abstract] [Full Text] [Related]
32. Interventions to increase cervical cancer screening rates.
Hitzeman N; Xavier EM
Am Fam Physician; 2012 Mar; 85(5):443-5. PubMed ID: 22534220
[No Abstract] [Full Text] [Related]
33. Management of cervical precancers: a global perspective.
Echelman D; Feldman S
Hematol Oncol Clin North Am; 2012 Feb; 26(1):31-44. PubMed ID: 22244660
[TBL] [Abstract][Full Text] [Related]
34. [On the best means of health education for the prevention and early diagnosis of uterine cancer].
Moracci E
Minerva Ginecol; 1968 Oct; 20(19):1562-8. PubMed ID: 5740785
[No Abstract] [Full Text] [Related]
35. Eradication of cervical cancer in Latin America.
Bosch FX
Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
[No Abstract] [Full Text] [Related]
36. [Testing of a computer based screening program for the registration of pre- and early stages of cervical carcinoma. I].
Seidenschnur G; Neumann HG; Hofmann H
Zentralbl Gynakol; 1973 Aug; 95(33):1137-41. PubMed ID: 4588175
[No Abstract] [Full Text] [Related]
37. [Implementation status of cervical screening in Europe].
Döbrőssy L; Cornides A; Kovács A; Budai A
Orv Hetil; 2014 Dec; 155(50):1975-88. PubMed ID: 25481500
[TBL] [Abstract][Full Text] [Related]
38. [Risk factors encountered in cases of cervix cancer and in precarcinomatous conditions (author's transl)].
Králová A
Cesk Gynekol; 1975 Aug; 40(7):551-6. PubMed ID: 1175244
[No Abstract] [Full Text] [Related]
39. [The importance of cytodiagnosis in the detection of cancer of the uterine cervix prophylactic examinations].
Skoblia ES; Korshun KZ
Vopr Onkol; 1969; 15(1):67-70. PubMed ID: 5784521
[No Abstract] [Full Text] [Related]
40. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
